Library
Conference Documents
Bioequivalence - Dr. Marilyn Martinez - FDA
VICH 5 Session 6: VICH NOW
Development of a VICH guideline on stability studies to address climatic zones III and IV - Dr. Alice Sigobodhla - Department of Health, South Africa
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
New VICH guideline on the efficacy studies for combination products - Dr. Ken Noda - JMAFF
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
New VICH guideline on residue studies in aquatic species - Dr. Pamela Boner - Zoetis/Topic leader for aquatic species in the MRK EWG
VICH 5 Session 7: Topics of particular interest for Observer Countries and VOF members
Outcome of the HealthforAnimals 2015 Global Animal Health Conference - Dr. Bettye Walters - Center for Veterinary Medicine, U.S. FDA
VICH 5 Session 8: Ongoing Activities: Global Perspectives
Regulatory perspective on trends in veterinary biologics - Dr. Byron Rippke - Center for Veterinary Biologics at USDA, APHIS, VS, CVB
VICH 5 Session 8: Ongoing Activities: Global Perspectives
Why regulatory convergence is important - Mr. Samuel J. Thevasagayam - Bill & Melinda Gates Foundation
VICH 5 Session 8: Ongoing Activities: Global Perspectives
The expectations from VICH Outreach Forum members - Dr. Carlos Francia - CAPROVE
VICH 5 Session 9: Finale
VICH and veterinary medicines availability - improvement of global animal & human health - Dr. Jean-Pierre Orand - OIE
VICH 5 Session 9: Finale
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.